Apex Biotechnology Corp (1733)

Currency in TWD
29.50
+0.65(+2.25%)
Closed·
1733 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
29.0029.65
52 wk Range
26.4038.70
Key Statistics
Bid/Ask
24.00 / 24.10
Prev. Close
33.15
Open
29
Day's Range
29-29.65
52 wk Range
26.4-38.7
Volume
131.26K
Average Volume (3m)
182.64K
1-Year Change
-6.9401%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
1733 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
163.00
Upside
+452.54%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Apex Biotechnology Corp News & Analysis

Show more

ApexBio Company Profile

Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. The company offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing. It also provides pesticide residue check systems; and care management and tele-health services. The company was incorporated in 1997 and is based in Hsinchu City, Taiwan.

Compare 1733 to Peers and Sector

Metrics to compare
1733
Peers
Sector
Relationship
P/E Ratio
19.1x0.0x−0.5x
PEG Ratio
0.430.000.00
Price/Book
1.6x0.0x2.6x
Price / LTM Sales
1.5x0.0x3.3x
Upside (Analyst Target)
-0.0%46.2%
Fair Value Upside
Unlock0.0%6.6%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 163.00
(+452.54% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.50%
Dividend Yield
3.99%
Industry Median 3.93%
Annualised payout
1.20
Paid annually
5-Years Growth
+1.76%
Growth Streak

Earnings

Latest Release
Nov 07, 2025
EPS / Forecast
0.22 / --
Revenue / Forecast
437.21M / --
EPS Revisions
Last 90 days

FAQ

What Is the ApexBio (1733) Share Price Today?

The live ApexBio share price today is 29.50

What Stock Exchange Does ApexBio (1733) Trade On?

ApexBio is listed and trades on the Taiwan Stock Exchange.

What Is the Ticker (Stock Symbol) for ApexBio?

The stock symbol (also called a 'ticker') for ApexBio is "1733."

Does ApexBio Pay Dividends? What’s The Current 1733 Dividend Yield?

Yes, 1733 Pays Dividends to its Shareholders. The current ApexBio dividend yield is 3.99%.

What Is the Current ApexBio Market Cap?

As of today, ApexBio market capitalisation is 2.88B.

What Is ApexBio's (1733) Earnings Per Share (TTM)?

The ApexBio EPS is currently 1.50 (Trailing Twelve Months).

When Is the Next ApexBio Earnings Date?

ApexBio's next earnings report will be released on 17 Mar 2026.

Is 1733 a Buy or Sell From a Technical Analyst Perspective?

Based on today's ApexBio moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has ApexBio Stock Split?

ApexBio has split 8 times. (See the 1733 stock split history page for full effective split date and price information.)

What is the current trading status of ApexBio (1733)?

As of 05 Feb 2026, ApexBio (1733) is trading at a price of 29.50, with a previous close of 33.15. The stock has fluctuated within a day range of 29.00 to 29.65, while its 52-week range spans from 26.40 to 38.70.

What Is ApexBio (1733) Price Target According to Analysts?

The average 12-month price target for ApexBio is TWD163.00, with a high estimate of TWD163 and a low estimate of TWD163. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +452.54% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.